Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Novartis CEO Says AI Could Shorten Drug Development to Eight Years

AI summary

Novartis CEO Vasant Narasimhan told Bloomberg that AI could cut drug-development time from 12 years to eight and significantly improve the odds of bringing medicines to market. He said AI is already helping Novartis speed up clinical trials, analyze data and identify new drug candidates.

This source provides an excerpt. Continue reading on the original site.

#Novartis

Read the original
Group chat

No comments yet. Start the conversation.